" class="no-js "lang="en-US"> Jenny (Yajin) Ni - Medtech Alert
Wednesday, March 22, 2023
Jenny (Yajin) Ni

Jenny (Yajin) Ni

About Jenny (Yajin) Ni

A seasoned Gene & Cell therapy product development scientist and manager involved in pioneering adaptive T cell therapy utilizing gene delivery and editing tools, provide scientific and technical leadership to define and guide phase appropriate manufacturing process development strategies and activities. Drive technology innovation for continued manufacturing process improvement through product clinical development cycles, interact with cross functional team and provide technical expertise and insight to influence important decision making during product clinical development phases. Strong project & team leadership management skills, extensive experience in manufacturing process & analytical method development, Tech-transfer, GMP manufacturing technical support, selection & management of CMO, IND CMC authoring & regulatory filing, IP authoring & filing, small biotech and big pharmaceutical industry experience.

Related Story

Gracell Biotechnologies Appoints Dr. Yajin Ni as CTO

May 12 2021

Gracell Biotechnologies Inc. (NASDAQ: GRCL) (“Gracell”), a global clinical-stage biopharmaceutical company dedicated to developing highly […]